drugset / Trial / NCT03543826
Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex
NaSingle-groupOpen-labelPrevention
Summary
This is an estimation study, prospectively evaluating the incidence of postoperative residual neuromuscular blockade (PRNB) when a best practice protocol is implemented for a cohort of abdominal surgery and orthopedic surgery patients. The protocol is developed within the constraint of subjective monitoring, quantitative monitoring is not used, and use of rocuronium for paralysis and either neostigmine or sugammadex for reversal. The primary outcome is the incidence of PRNB on arrival to the post-anesthesia care unit, defined as a train-of-four ration \<0.9.
Timeline
- Start
- 2018-05-21
- Primary completion
- 2018-11-26
- Completion
- 2018-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neostigmine | Other / unclassified | — | — |
| Subject | Rocuronium | Other / unclassified | — | — |
| Subject | Sugammadex | Other / unclassified | — | — |